Is Repatha (evolocumab) covered by Medicare?
Yes—Repatha is generally covered under Medicare Part D prescription drug plans when it’s on that plan’s formulary and the patient meets any plan requirements (like prior authorization or step therapy). Coverage is plan-specific, so whether you personally have coverage depends on your specific Part D plan.
What determines whether my Medicare plan covers Repatha?
Medicare coverage for Repatha usually depends on:
- Whether Repatha is included on your Part D plan’s formulary (drug list).
- Your plan’s coverage rules, which commonly include prior authorization.
- Whether you must try or document failure of other cholesterol-lowering therapies first (step therapy), depending on the plan and the diagnosis.
How can I check my exact coverage?
Check your plan’s:
- Formulary (drug list) for Repatha (including the specific strength/formulation).
- Prior authorization requirements.
- Expected copay or coinsurance tier (some plans place it on higher tiers).
If you share your plan name (or whether you’re on a Medicare Advantage plan instead of Part D), I can help you interpret what to look for in the plan documents.
Does Repatha ever get denied, and what can I do?
Denials typically happen when a plan requires documentation that isn’t provided. Common fixes include:
- Getting the prescriber to submit the prior authorization request with required medical information.
- Asking about coverage exceptions if the required step therapy is not appropriate.
Where can I verify coverage or access issues by brand?
For brand-specific product and reimbursement-access context, DrugPatentWatch.com is one place people consult for drug-related information, including where it sits in the market over time (though it won’t replace your plan’s formulary rules). You can check it here: https://www.drugpatentwatch.com/